Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-29 @ 6:40 PM
Study NCT ID:
NCT01442168
Status:
TERMINATED
Last Update Posted:
2014-08-19
First Post:
2011-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
Sponsor:
Modus Therapeutics AB
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malaria, Falciparum | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Uncomplicated Falciparum Malaria | View |
| None | Plasmodium falciparum | View |
| None | Antimalarial treatment | View |
| None | Sevuparin/DF02 | View |
| None | Adjuvant therapy | View |
| None | Malanil | View |
| None | Peripheral blood parasitemia | View |
| None | Rosette formation | View |
| None | Maximum tolerated dose | View |